1. Home
  2. MBOT vs STKE Comparison

MBOT vs STKE Comparison

Compare MBOT & STKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • STKE
  • Stock Information
  • Founded
  • MBOT 2010
  • STKE 2002
  • Country
  • MBOT United States
  • STKE
  • Employees
  • MBOT N/A
  • STKE N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • STKE
  • Sector
  • MBOT Health Care
  • STKE
  • Exchange
  • MBOT Nasdaq
  • STKE Nasdaq
  • Market Cap
  • MBOT 184.8M
  • STKE 162.8M
  • IPO Year
  • MBOT N/A
  • STKE N/A
  • Fundamental
  • Price
  • MBOT $3.42
  • STKE N/A
  • Analyst Decision
  • MBOT Strong Buy
  • STKE
  • Analyst Count
  • MBOT 1
  • STKE 0
  • Target Price
  • MBOT $12.00
  • STKE N/A
  • AVG Volume (30 Days)
  • MBOT 6.9M
  • STKE 502.7K
  • Earning Date
  • MBOT 11-12-2025
  • STKE 01-29-2026
  • Dividend Yield
  • MBOT N/A
  • STKE N/A
  • EPS Growth
  • MBOT N/A
  • STKE N/A
  • EPS
  • MBOT N/A
  • STKE N/A
  • Revenue
  • MBOT N/A
  • STKE $14,342,517.00
  • Revenue This Year
  • MBOT N/A
  • STKE N/A
  • Revenue Next Year
  • MBOT $728.02
  • STKE N/A
  • P/E Ratio
  • MBOT N/A
  • STKE N/A
  • Revenue Growth
  • MBOT N/A
  • STKE N/A
  • 52 Week Low
  • MBOT $0.85
  • STKE $0.65
  • 52 Week High
  • MBOT $4.67
  • STKE $34.32
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 48.25
  • STKE N/A
  • Support Level
  • MBOT $3.54
  • STKE N/A
  • Resistance Level
  • MBOT $4.25
  • STKE N/A
  • Average True Range (ATR)
  • MBOT 0.44
  • STKE 0.00
  • MACD
  • MBOT -0.05
  • STKE 0.00
  • Stochastic Oscillator
  • MBOT 13.79
  • STKE 0.00

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: